Precipio, Inc. (NASDAQ:PRPO) Short Interest Down 14.3% in June

Precipio, Inc. (NASDAQ:PRPO) was the target of a large decrease in short interest in the month of June. As of June 15th, there was short interest totalling 1,200 shares, a decrease of 14.3% from the May 31st total of 1,400 shares. Based on an average daily volume of 4,200 shares, the days-to-cover ratio is currently 0.3 days. Currently, 0.1% of the shares of the stock are sold short.

Precipio Stock Up 4.4 %

NASDAQ:PRPO opened at $5.19 on Friday. The company has a quick ratio of 0.62, a current ratio of 0.78 and a debt-to-equity ratio of 0.01. Precipio has a fifty-two week low of $4.65 and a fifty-two week high of $8.99. The firm’s fifty day simple moving average is $5.76 and its 200-day simple moving average is $6.14.

Precipio (NASDAQ:PRPO) last posted its quarterly earnings results on Tuesday, May 14th. The biotechnology company reported ($1.46) earnings per share for the quarter. Precipio had a negative return on equity of 46.12% and a negative net margin of 31.00%. The company had revenue of $3.43 million for the quarter.

Precipio Company Profile

Precipio, Inc, a healthcare solutions company, provides diagnostic products, reagents, and services in the United States. It provides diagnostic blood cancer testing services. The company offers IV-Cell, a proprietary cell culture media that enables simultaneous culturing of four hematopoietic cell lineages; and HemeScreen, a suite of robust genetic diagnostic panels.